Medicaid Coverage Policy Variations for Chronic Pain and Opioid Use Disorder Treatment

Citation

Adams MCB, Eller SM, McDonnell C, Sritharan S, Chikoti R, Alwani A, Hill EL, Hurley RW. Medicaid Coverage Policy Variations for Chronic Pain and Opioid Use Disorder Treatment. JAMA Netw Open. 2025 Aug 1;8(8):e2526796. doi: 10.1001/jamanetworkopen.2025.26796. PMID: 40802182; PMCID: PMC12351411.

Article Type

Original Research (Systematic Economic Evaluation)

Topic Area

Policy and Health Systems; Pain Medicine; Opioid Use and Misuse

Population

Medicaid coverage policies across all 50 US states and the District of Columbia for chronic pain and OUD treatments

Summary

Co-occurring chronic pain and opioid use disorder (OUD) present a high disease burden requiring comprehensive, multimodal treatment approaches. However, Medicaid, the primary insurance coverage for many individuals with these conditions, varies substantially across states in its benefit structures for evidence-based therapies. This systematic economic evaluation developed a framework for analyzing Medicaid coverage policy variations in behavioral and integrative health services for co-occurring chronic pain and OUD. The authors reviewed Medicaid coverage policies across all 50 states and the District of Columbia, examining benefits for treatments including physical therapy, cognitive behavioral therapy, acupuncture, and medications for OUD. The analysis revealed significant state-by-state variation in coverage for evidence-based pain and OUD treatments, with many states imposing restrictions such as prior authorization requirements, visit limits, and narrow provider eligibility criteria. These policy variations create geographic inequities in treatment access that disproportionately affect vulnerable populations dependent on Medicaid coverage. The findings highlight the need for policy reform to ensure more uniform access to evidence-based chronic pain and OUD treatments across state Medicaid programs.

Background

Chronic pain and OUD frequently co-occur, yet treatment for these conditions often occurs in siloed systems. Medicaid is the single largest payer for OUD treatment in the United States, but state-level variation in covered benefits means that access to evidence-based multimodal treatments differs dramatically depending on where a patient lives.

Methods

The authors conducted a systematic review of Medicaid coverage policies across all 50 states and the District of Columbia, focusing on behavioral health, integrative medicine, and pharmacologic treatments for chronic pain and OUD. A structured framework was developed to categorize and compare coverage policies, restrictions, and access barriers.

Key Findings

Substantial interstate variation was identified in Medicaid coverage for chronic pain and OUD treatments. Many states imposed restrictive policies including prior authorization requirements, visit limits, and narrow definitions of covered services. Coverage for integrative and behavioral health approaches to pain management was particularly inconsistent across states.

Implications for Practice and Policy

These findings provide evidence for policy reform efforts aimed at reducing geographic disparities in pain and OUD treatment access. Federal guidance or incentives encouraging states to adopt more comprehensive Medicaid coverage for evidence-based multimodal pain and OUD treatment could improve outcomes for vulnerable populations.

Future Directions

Future research should examine how Medicaid coverage variations relate to patient-level treatment outcomes, healthcare utilization, and overdose rates across states, and evaluate the impact of specific policy changes on treatment access.

Keywords

Medicaid policy, chronic pain, opioid use disorder, coverage disparities, health policy, treatment access, behavioral health, integrative medicine, health equity, state variation